Aspiriant LLC’s iShares Russell 1000 Growth ETF IWF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.66M Sell
24,980
-5,784
-19% -$657K 0.08% 95
2025
Q4
$3.64M Buy
30,764
+480
+2% +$56.9K 0.1% 86
2025
Q3
$3.55M Sell
30,284
-9,700
-24% -$1.08M 0.11% 80
2025
Q2
$4.24M Buy
39,984
+452
+1% +$43.2K 0.13% 70
2025
Q1
$3.57M Hold
39,532
0.12% 65
2024
Q4
$3.97M Buy
39,532
+564
+1% +$55.5K 0.14% 63
2024
Q3
$3.66M Buy
38,968
+5,048
+15% +$458K 0.14% 68
2024
Q2
$3.09M Buy
33,920
+712
+2% +$60.8K 0.13% 72
2024
Q1
$2.8M Sell
33,208
-140
-0.4% -$11.3K 0.12% 80
2023
Q4
$2.53M Sell
33,348
-424
-1% -$30K 0.11% 81
2023
Q3
$2.25M Sell
33,772
-976
-3% -$67.4K 0.11% 84
2023
Q2
$2.39M Buy
34,748
+436
+1% +$27.7K 0.12% 83
2023
Q1
$2.1M Buy
34,312
+900
+3% +$51.9K 0.11% 86
2022
Q4
$1.79M Sell
33,412
-1,688
-5% -$92.9K 0.09% 93
2022
Q3
$1.85M Buy
35,100
+1,488
+4% +$87.5K 0.09% 87
2022
Q2
$1.84M Buy
33,612
+132
+0.4% +$7.92K 0.09% 86
2022
Q1
$2.32M Sell
33,480
-2,436
-7% -$166K 0.13% 80
2021
Q4
$2.74M Buy
35,916
+1,280
+4% +$94.9K 0.15% 76
2021
Q3
$2.37M Hold
34,636
0.14% 71
2021
Q2
$2.35M Buy
34,636
+7,224
+26% +$466K 0.13% 69
2021
Q1
$1.67M Sell
27,412
-368
-1% -$22.4K 0.11% 72
2020
Q4
$1.67M Sell
27,780
-440
-2% -$25K 0.11% 74
2020
Q3
$1.53M Sell
28,220
-1,224
-4% -$64.5K 0.12% 80
2020
Q2
$1.41M Sell
29,444
-2,004
-6% -$88.3K 0.13% 66
2020
Q1
$1.18M Sell
31,448
-1,464
-4% -$63.1K 0.12% 70
2019
Q4
$1.45M Sell
32,912
-2,752
-8% -$115K 0.13% 70
2019
Q3
$1.42M Buy
35,664
+2,916
+9% +$117K 0.13% 83
2019
Q2
$1.29M Sell
32,748
-832
-2% -$32.2K 0.11% 92
2019
Q1
$1.27M Hold
33,580
0.1% 94
2018
Q4
$1.1M Sell
33,580
-6,420
-16% -$226K 0.08% 100
2018
Q3
$1.56M Buy
40,000
+9,064
+29% +$343K 0.13% 90
2018
Q2
$1.11M Sell
30,936
-7,708
-20% -$272K 0.1% 101
2018
Q1
$1.31M Buy
38,644
+28,860
+295% +$1.01M 0.11% 91
2017
Q4
$329K Sell
9,784
-48,296
-83% -$1.58M 0.1% 60
2017
Q3
$1.82M Sell
58,080
-8,056
-12% -$247K 0.15% 81
2017
Q2
$1.97M Sell
66,136
-4,092
-6% -$120K 0.17% 80
2017
Q1
$2M Sell
70,228
-23,084
-25% -$640K 0.17% 83
2016
Q4
$2.45M Sell
93,312
-27,400
-23% -$711K 0.22% 68
2016
Q3
$3.14M Sell
120,712
-33,128
-22% -$861K 0.31% 48
2016
Q2
$3.86M Sell
153,840
-38,984
-20% -$973K 0.36% 45
2016
Q1
$4.81M Buy
192,824
+23,788
+14% +$562K 0.46% 35
2015
Q4
$4.2M Buy
169,036
+84,140
+99% +$2.1M 0.46% 24
2015
Q3
$1.97M Buy
84,896
+1,172
+1% +$28.8K 0.16% 39
2015
Q2
$2.07M Buy
83,724
+56
+0.1% +$1.41K 0.2% 27
2015
Q1
$2.07M Sell
83,668
-5,464
-6% -$133K 0.27% 27
2014
Q4
$2.13M Sell
89,132
-23,104
-21% -$541K 0.28% 27
2014
Q3
$2.57M Buy
112,236
+3,980
+4% +$91.2K 0.36% 19
2014
Q2
$2.46M Sell
108,256
-1,300
-1% -$28.5K 0.34% 22
2014
Q1
$2.37M Buy
109,556
+20,456
+23% +$439K 0.34% 23
2013
Q4
$1.92M Buy
89,100
+72,600
+440% +$1.49M 0.3% 26
2013
Q3
$323K Sell
16,500
-95,448
-85% -$1.83M 0.06% 45
2013
Q2
$2.04M Buy
+111,948
New +$2.05M 0.32% 20

Other funds holding IWF

Aspiriant LLC's IWF Position: Q1 2026 in Review

Aspiriant LLC reduced its iShares Russell 1000 Growth ETF (IWF) stake by 19% in Q1 2026, selling an estimated $657K and leaving 24,980 shares worth $2.66M. The position accounts for 0.08% of the portfolio, ranked #95.

Aspiriant LLC first reported a position in IWF in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.81M in Q1 2016. 2,432 funds tracked by Wall St. Rank hold IWF as of Q1 2026.

  • Aspiriant LLC held 24,980 shares of iShares Russell 1000 Growth ETF worth $2.66M as of Q1 2026.
  • Aspiriant LLC sold 5,784 iShares Russell 1000 Growth ETF shares in Q1 2026, an estimated $657K.
  • iShares Russell 1000 Growth ETF made up 0.08% of Aspiriant LLC's portfolio in Q1 2026, its #95 holding.
  • Aspiriant LLC first reported a position in iShares Russell 1000 Growth ETF in Q2 2013 and has held it in 52 quarters since.
  • Aspiriant LLC's iShares Russell 1000 Growth ETF position peaked at $4.81M in Q1 2016.
  • 2,432 funds tracked by Wall St. Rank held iShares Russell 1000 Growth ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.